A detailed history of Nuveen Asset Management, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 270,184 shares of PACB stock, worth $475,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
270,184
Previous 270,184 -0.0%
Holding current value
$475,523
Previous $370,000 24.05%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.36 - $3.65 $557,249 - $1.5 Million
-409,742 Reduced 60.26%
270,184 $370,000
Q1 2024

May 13, 2024

BUY
$3.52 - $9.59 $49,705 - $135,420
14,121 Added 2.12%
679,926 $2.55 Million
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $42,130 - $73,110
7,057 Added 1.07%
665,805 $6.53 Million
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $35,232 - $59,634
-4,281 Reduced 0.65%
658,748 $5.5 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $52,153 - $73,495
5,231 Added 0.8%
663,029 $8.82 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $375,633 - $568,654
-47,309 Reduced 6.71%
657,798 $7.62 Million
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $949,895 - $1.88 Million
-167,530 Reduced 19.2%
705,107 $5.77 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $40,392 - $88,082
-10,278 Reduced 1.16%
872,637 $5.07 Million
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $753,299 - $1.95 Million
-187,388 Reduced 17.51%
882,915 $3.9 Million
Q1 2022

May 16, 2022

SELL
$8.43 - $20.9 $863,358 - $2.14 Million
-102,415 Reduced 8.73%
1,070,303 $10.6 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $1.48 Million - $2.31 Million
-76,841 Reduced 6.15%
1,172,718 $24 Million
Q3 2021

Nov 12, 2021

SELL
$24.86 - $35.02 $721,437 - $1.02 Million
-29,020 Reduced 2.27%
1,249,559 $36.8 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $3.57 Million - $5.77 Million
160,159 Added 14.32%
1,278,579 $44.7 Million
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $7.4 Million - $14.4 Million
280,568 Added 33.49%
1,118,420 $37.3 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $1.84 Million - $5 Million
175,450 Added 26.49%
837,852 $21.7 Million
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $366,220 - $1 Million
101,446 Added 18.08%
662,402 $6.54 Million
Q2 2020

Aug 14, 2020

SELL
$2.65 - $4.03 $32,139 - $48,875
-12,128 Reduced 2.12%
560,956 $1.94 Million
Q1 2020

May 14, 2020

BUY
$2.36 - $5.26 $46,239 - $103,059
19,593 Added 3.54%
573,084 $1.75 Million
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $3,169 - $3,837
-689 Reduced 0.12%
553,491 $2.85 Million
Q3 2019

Nov 14, 2019

BUY
$4.99 - $6.16 $61,556 - $75,989
12,336 Added 2.28%
554,180 $2.86 Million
Q2 2019

Aug 15, 2019

BUY
$5.92 - $7.41 $3.21 Million - $4.02 Million
541,844 New
541,844 $3.28 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $396M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.